Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase

首次发布于 2022 年 5 月 6 日

Outcomes After Planned Discontinuation of AntiSeizure Medication

计划入组 40 人 · 首次发布于 2026 年 8 月 6 日

Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding

计划入组 60 人 · 首次发布于 2022 年 7 月 11 日

Anti-Aging Medications(Chengdu WestGene Biopharma )

Sotrastaurin

C₂₅H₂₂N₆O₂

Camphene

C₁₀H₁₆

CONTROLLED MEDICATIONS LIMITED

Hong Kong, China

PFIZER INC.

United States

Incyte Corporation

United States

Newer Antiseizure Medications Show Improved Safety Profile During Pregnancy

Antiseizure Medication Choice Alters Stroke and Bleeding Risk in Epilepsy Patients on DOACs

Newer Epilepsy Medications During Pregnancy Show No Impact on Children's Neurodevelopment at Age 6